{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:12:32Z","timestamp":1791130352086,"version":"4.1.0"},"reference-count":23,"publisher":"American Psychiatric Association Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1176\/appi.ps.54.7.1006","type":"journal-article","created":{"date-parts":[[2003,7,8]],"date-time":"2003-07-08T16:33:00Z","timestamp":1057681980000},"page":"1006-1011","source":"Crossref","is-referenced-by-count":80,"title":["Lack of Relationship Between Long-Term Use of Benzodiazepines and Escalation to High Dosages"],"prefix":"10.1176","volume":"54","author":[{"given":"Stephen B.","family":"Soumerai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Simoni-Wastila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Ross-Degnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R5471132","doi-asserted-by":"crossref","unstructured":"Shader RI, Greenblatt DJ: Use of benzodiazepines in anxiety disorders. New England Journal of Medicine 328:1398\u20131405, 1993","DOI":"10.1056\/NEJM199305133281907"},{"key":"R5471133","doi-asserted-by":"crossref","unstructured":"Woods JH, Winger G: Current benzodiazepine issues. Psychopharmacology 118:107\u2013115, 1995","DOI":"10.1007\/BF02245824"},{"key":"R5471134","unstructured":"Ballenger JC: Long-term pharmacologic treatment of panic disorder. Journal of Clinical Psychiatry 52(suppl 12):18\u201323, 1991"},{"key":"R5471135","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder. American Journal of Psychiatry 151(suppl 12):1\u201335, 1994","DOI":"10.1176\/ajp.151.12.1"},{"key":"R5471137","doi-asserted-by":"crossref","unstructured":"Uhlenhuth EH, Balter MB, Ban TA, et al: International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. Journal of Clinical Psychopharmacology 19:23S-29S, 1999","DOI":"10.1097\/00004714-199912002-00005"},{"key":"R5471138","doi-asserted-by":"crossref","unstructured":"Wright N, Caplan R, Payne S: Community survey of long-term daytime use of benzodiazepines. British Medical Journal 309:27\u201328, 1994","DOI":"10.1136\/bmj.309.6946.27"},{"key":"R5471139","doi-asserted-by":"crossref","unstructured":"Posternak MA, Mueller TI: Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence. American Journal of Addictions 10:48\u201368, 2001","DOI":"10.1080\/105504901750160484"},{"key":"R54711311","doi-asserted-by":"crossref","unstructured":"Salzman C: Addiction to benzodiazepines. Psychiatric Quarterly 69:251\u2013261, 1998","DOI":"10.1023\/A:1022125929946"},{"key":"R54711312","doi-asserted-by":"crossref","unstructured":"Spiegel DA: Psychological strategies for discontinuing benzodiazepine treatment. Journal of Clinical Psychopharmacology 19:17S-22S, 1999","DOI":"10.1097\/00004714-199912002-00004"},{"key":"R54711313","doi-asserted-by":"crossref","unstructured":"Ishigooka J, Sugiyama T, Suzuki M, et al: Survival analytic approach to long-term prescription of benzodiazepine hypnotics. Psychiatry and Clinical Neurosciences 52:541\u2013545, 1998","DOI":"10.1046\/j.1440-1819.1998.00422.x"},{"key":"R54711314","unstructured":"Davidson JR: Continuation treatment of panic disorder with high-potency benzodiazepines. Journal of Clinical Psychiatry 51 (suppl A):31\u201337, 1990"},{"key":"R54711315","doi-asserted-by":"crossref","unstructured":"Pollack MH, Tesar GE, Rosenbaum JF, et al: Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. Journal of Clinical Psychopharmacology 6:302\u2013304, 1986","DOI":"10.1097\/00004714-198610000-00010"},{"key":"R54711316","doi-asserted-by":"crossref","unstructured":"Sheehan DV: Benzodiazepines in panic disorder and agoraphobia. Journal of Affective Disorders 13:169\u2013181, 1987","DOI":"10.1016\/0165-0327(87)90021-8"},{"key":"R54711318","doi-asserted-by":"crossref","unstructured":"Soumerai SB, Avorn J, Ross-Degnan D, et al: Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity. New England Journal of Medicine 317:550\u2013556, 1987","DOI":"10.1056\/NEJM198708273170906"},{"key":"R54711319","doi-asserted-by":"crossref","unstructured":"Soumerai SB, Ross-Degnan DG, Avorn J, et al: Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. New England Journal of Medicine 325:1072\u20131077, 1991","DOI":"10.1056\/NEJM199110103251505"},{"key":"R54711320","doi-asserted-by":"crossref","unstructured":"Soumerai SB, McLaughlin TJ, Ross-Degnan DG, et al: Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine 331:650\u2013655, 1994","DOI":"10.1056\/NEJM199409083311006"},{"key":"R54711321","doi-asserted-by":"crossref","unstructured":"Soumerai SB, Ross-Degnan DG, Gortmaker S, et al: Withdrawing payment for non-scientific drug therapy: intended and unexpected effects of a large scale natural experiment. JAMA 263:831\u2013839, 1990","DOI":"10.1001\/jama.263.6.831"},{"key":"R54711322","doi-asserted-by":"crossref","unstructured":"Federspiel CF, Ray WA, Schaffner W: Medicaid records as a valid data source: the Tennessee experience. Medical Care 14:166\u2013172, 1976","DOI":"10.1097\/00005650-197602000-00006"},{"key":"R54711326","doi-asserted-by":"crossref","unstructured":"Sheikh JI, Salzman C: Anxiety in the elderly: course and treatment. Psychiatric Clinics of North America 18:871\u2013883, 1995","DOI":"10.1016\/S0193-953X(18)30028-5"},{"key":"R54711327","doi-asserted-by":"crossref","unstructured":"Gillings D, Makuc D, Siegel E: Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. American Journal of Public Health 71:38\u201346, 1981","DOI":"10.2105\/AJPH.71.1.38"},{"key":"R54711328","doi-asserted-by":"crossref","unstructured":"Wagner AK, Soumerai SB, Zhang F, et al: Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 27:299\u2013309, 2002","DOI":"10.1046\/j.1365-2710.2002.00430.x"},{"key":"R54711330","doi-asserted-by":"crossref","unstructured":"Woods JH, Katz JL, Winger G: Use and abuse of benzodiazepines: issues relevant to prescribing. JAMA 260:3476\u20133480, 1988","DOI":"10.1001\/jama.260.23.3476"},{"key":"R54711331","doi-asserted-by":"crossref","unstructured":"Mellinger GD, Balter MB, Uhlenhuth EH: Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 251:375\u2013379, 1984","DOI":"10.1001\/jama.251.3.375"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.54.7.1006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T13:43:24Z","timestamp":1722174204000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.54.7.1006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1176\/appi.ps.54.7.1006"],"URL":"https:\/\/doi.org\/10.1176\/appi.ps.54.7.1006","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}